Further complicating SCLC-Y classification, some previously identified YAP1-positive SCLC cell lines have been reclassified as SMARCA4-mutant undifferentiated tumors (SMARCA4-UT), a distinct entity with aggressive biology and poor differentiation [37]. Here, SMARCA4 is linked to small cell lung carcinoma.